CliffBio
small molecule

METFORMIN HYDROCHLORIDE

METFORMIN HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanySAPTALIS PHARMACEUTICALS LLC

Drug detail

Brand nameMETFORMIN HYDROCHLORIDE
Active ingredientMETFORMIN HYDROCHLORIDE
Strength500MG/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2020
Marketing statusRX

More from SAPTALIS PHARMACEUTICALS LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

METFORMIN HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio